US University evaluates Long Term Cardiovascular and Pulmonary Complications After COVID-19 With Point of Care Ultrasound

The University of Louisville is enrolling patients into the clinical trial investigating Evaluate Long Term Cardiovascular and Pulmonary Complications After COVID-19 With Point of Care Ultrasound.

The researchers hypothesize that recovered COVID-19 patients suffer long term cardiovascular and pulmonary complications, which can be detected by point of care ultrasound. The goal is to comprehensively delineate the long term cardiovascular and pulmonary ultrasound findings in recovered COVID-19 patients, identify risks factors for prolonged heart/lung injury, evaluate long term effects of applied treatment, and assess late medication/vaccine side effects in COVID-19 patients.

The trial is designed to enroll male and female 18 years and older and is being conducted in the University of Louisville Health, Louisville, Kentucky, United States.

The study start date is April 1, 2021.

The patients that can be enrolled into this study include:

• >18 years of age
• Consent to participate in this research
• Confirmed SARS-CoV-2 infection by RT-PCR or serological tests

The link to the complete study profile: https://ichgcp.net/clinical-trials-registry/NCT04756193